Analysis of potential drug interaction in children under 10 years of age with acute respiratory tract infections at RSIA Sitti Khadijah hospital in Makassar
DOI:
https://doi.org/10.35814/jifi.v24i1.2058Keywords:
Acute Respiratory Tract Infection (ARI), drug interaction, pediatri, pharmacodynamic, retrospective studyAbstract
Acute Respiratory Tract Infection (ARI) is one of the most prevalent diseases, triggered by various factors such as microorganisms and air pollution. This study aimed to analyze the risk of drug interactions in pediatric ARI patients under 10 years of age at RSIA Sitti Khadijah Makassar from July to December 2024. A non-experimental retrospective design was applied using data collected from outpatient medical records.The findings indicated that 75% of patients having potential drug interactions predominantly in the moderate category with a pharmacodynamic mechanism. The primary factor contributing to these interactions was the concurrent use of multiple drugs. Such interactions can alter therapeutic effectiveness by either enhancing or reducing drug effects; therefore, early identification and appropriate management of drug interactions are essential to optimize treatment outcomes and minimize adverse effects. Greater attention to potential drug interactions in pediatric ARI therapy is crucial to ensure treatment safety and effectiveness.
References
[1] K. F. Lestari et al., “Peningkatan pengetahuan masyarakat tentang ıspa melalui pendidikan kesehatan Di Desa Kanuna Kecamatan Kinovaro Kabupaten Sigi,” EJOIN J. Pengabdi. Masy., vol. 1, no. 4, pp. 310–313, 2023, doi: 10.55681/ejoin.v1i4.771.
[2] W. Anggraini, S. Aisyah, and E. Afrika, “Faktor-Faktor yang behubungan dengan kejadian Infeksi Saluran Pernapasan Akut (ISPA) pada balita dı Puskesmas Kemalaraja Kabupaten Ogan Komering Ulu tahun 2023,” J. Kesehat. Saintika Meditory, vol. 6, no. 2, pp. 205–213, 2023.
[3] D. R. Wijaya, T. Wulandari, and Nildawati, “Exclusive breastfeeding and smoking behavior as determinants of ARI in toddlers,” Community Res. Epidemiol., vol. 4, no. 1, pp. 52–61, 2023, doi: 10.24252/corejournal.vi.43122.
[4] A. T. Sari and N. Indriyanti, “Laporan kasus: penanganan efek samping pseudoefedrin pada pasien ISPA anak,” J. Sains dan Kesehat., vol. 4, no. 2, pp. 231–233, 2022, doi: 10.25026/jsk.v4i2.781.
[5] W. Amelia, “Evaluasi ınteraksi obat sebagai Drug Related Problems (DRPS) pada pasien Infeksi Saluran Pernapasan Akut (ISPA) Di RSI Fatimah Cilacap,” vol. 5, no. 3, pp. 248–253, 2020.
[6] J. Simanjuntak, E. Santoso, and Marji, “Klasifikasi penyakit Infeksi Saluran Pernapasan Akut ( ISPA ) dengan menerapkan metode fuzzy k-nearest neighbor,” J. Pengemb. Teknol. Inf. dan Ilmu Komput., vol. 5, no. 11, pp. 5023–5029, 2021.
[7] N. Rasdianah and A. S. W. Gani, “Interaksi Obat pada pasien diabetes melitus tipe 2 dengan penyakit penyerta di Rumah Sakit Otanaha Kota Gorontalo,” Indones. J. Pharm. Educ., vol. 1, no. 1, pp. 40–46, 2021, doi: 10.37311/ijpe.v1i1.9953.
[8] D. Rosita, “Faktor-faktor yang mempengaruhi kejadian ISPA pada balita di RSUD RA Kartini Kabupaten Jepara suatu metode penellitian yang di lakukan mengetahui nilai variabel mandiri , baik satu variabel,” vol. 41, pp. 1–5, 2024.
[9] U. Ashofa and W. W. Timur, “Hubungan ınteraksi obat pada pasien pediatrik rawat ınap Rumah Sakit Islam Sultan Agung Semarang Periode 2020,” Pros. Konstelasi Ilm. Mhs. Unissula 7, vol. 1, no. 1, pp. 42–52, 2021.
[10] F. Ulfa, E. S. Pradana, and K. Lestari, “Identifikasi Potensi Interaksi Antar Obat Pada Resep Spesialis Penyakit Dalam Di Salah Satu Apotek Di Kota Bandung,” J. Farmaka, vol. 19, pp. 7–14, 2021.
[11] H. Humaira Fadhilah, G. Aulia, and E. S. Delia, “Evaluasi Penggunaan obat penyakit Infeksi Saluran Pernafasan Akut (ISPA) pada anak di ınstalasi Rawat Inap RSIA Citra Insani,” J. Pharm. Sci., vol. 2, no. 2, pp. 99–109, 2022.
[12] I. B. M. Reyaan, C. Kuning, and I. K. Adnyana, “Studi potensi ınteraksi obat pada resep polifarmasi di dua apotek Kota Bandung,” J. Manaj. DAN PELAYANAN Farm. (Journal Manag. Pharm. Pract., vol. 11, no. 3, p. 145, 2021, doi: 10.22146/jmpf.56931.
[13] F. P. Rahayu and Y. Susilawati, “Identifikasi ınteraksi obat pada resep tentang gangguan pernapasan di bulan februari 2023 di apotek Kota Bandung,” J. Farmaka , vol. 21, no. 3, pp. 298–305, 2023, [Online]. Available: www.medscape.com
[14] A. Aztriana, A. M. Mursyid, W. O. P. Sukaenah, and V. Purnamasari M, “Profil pengkajian resep racikan pasien pediatri rawat jalan di apotek RSKD Ibu dan anak siti fatimah Kota Makassar,” J. Kesehat. Tambusai, vol. 4, no. 4, pp. 5819–5831, 2023, doi: 10.31004/jkt.v4i4.17418.
[15] R. D. Widodo, M. Muliyani, N. Isnani, and M. Zaini, “Gambaran potensi ınteraksi obat kortikosteroid pada pasien pneumonia anak di ınstalasi rawat ınap RSUD Ulin Banjarmasin,” J. Kaji. Ilm. Kesehat. dan Teknol., vol. 5, no. 2, pp. 131–137, 2023, doi: 10.52674/jkikt.v5i2.117.
[16] B. Hanutami and K. L. Dandan, “Identifikasi potensi ınteraksi antar obat pada resep umum di apotek kimia farma 58 Kota Bandung bulan April 2023,” Farmaka, vol. 17, no. 2, pp. 57–64, 2023.
[17] M. L. Pasaribu and M. Imron, “Identifikasi potensi ınteraksi antar obat pada resep umum di apotek nurmas kota Blitar selama bulan januari - februari 2025 ıdentification of potential drug ınteractions in general prescriptions at nurmas pharmacy in Blitar City during JANUARY - FEBRUARY 2025,” vol. 1, no. February, pp. 15–20, 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 JURNAL ILMU KEFARMASIAN INDONESIA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















